Topical capsaicin (low concentration) for chronic neuropathic pain in adults (Q24200378)

2 July 2019

title

Topical capsaicin (low concentration) for chronic neuropathic pain in adults (English)

1 reference

2 July 2019

main subject

neuropathic pain

0 references

chronic pain

0 references

chronic neuropathic pain

0 references

author

Sheena Derry

series ordinal

1

0 references

Robert Andrew Moore

series ordinal

2

object named as

R Andrew Moore

0 references

publication date

12 September 2012

1 reference

2 July 2019

Cochrane Database of Systematic Reviews

published in

1 reference

2 July 2019

page(s)

CD010111

1 reference

2 July 2019

issue

9

1 reference

2 July 2019

Treatment of painful diabetic neuropathy with capsaicin 0.075%.

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Topical Capsaicin in Painful Diabetic Neuropathy: Controlled Study With Long-Term Follow-Up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

The postmastectomy pain syndrome and topical capsaicin: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Analgesic effect of capsaicin in idiopathic trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Topical capsaicin in the management of HIV-associated peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

A highly successful and novel model for treatment of chronic painful diabetic peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Analysis of 50 patients with atypical odontalgia. A preliminary report on pharmacological procedures for diagnosis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Post-herpetic neuralgia and topical capsaicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

The post-mastectomy pain syndrome and the effect of topical capsaicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

The visual analogue pain intensity scale: what is moderate pain in millimetres?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

The number needed to treat: a clinically useful measure of treatment effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Epidemiology and treatment of neuropathic pain: the UK primary care perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Meta-analysis in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Reporting of adverse drug reactions in randomised controlled trials - a systematic survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Systematic review of topical capsaicin for the treatment of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Pregabalin for acute and chronic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

"Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Prevalence and comorbidity of chronic pain in the German general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Pharmacological treatment of diabetic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Pregabalin in fibromyalgia--responder analysis from individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

The prevalence and impact of chronic pain with neuropathic pain symptoms in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

The prevalence of neuropathic pain: clinical evaluation compared with screening tools in a community population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

Topical capsaicin for chronic neuropathic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010111

A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy.

21 January 2018

1 reference

12 December 2020

Reporting of Adverse Effects in Clinical Trials Should Be Improved

1 reference

12 December 2020

Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Capsaicin Study Group

1 reference

12 December 2020

Does capsaicin relieve the pain of diabetic neuropathy?

1 reference

12 December 2020

Topical 0.025% capsaicin in chronic post-herpetic neuralgia: efficacy, predictors of response and long-term course

1 reference

12 December 2020

Capsaicin: a therapeutic option for painful diabetic neuropathy

1 reference

12 December 2020

Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. The Capsaicin Study Group

1 reference

12 December 2020

Topical capsaicin treatment of chronic postherpetic neuralgia.

1 reference

12 December 2020

A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia

1 reference

12 December 2020

Developing a database of published reports of randomised clinical trials in pain research

1 reference

12 December 2020

Treatment of intractable pain with topical large-dose capsaicin: preliminary report

1 reference

12 December 2020

10.1002/14651858.CD010111

Identifiers

DOI

1 reference

2 July 2019

OpenCitations bibliographic resource ID

3269375

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

2 July 2019

PubMed ID

22972149

1 reference

2 July 2019